Stockreport

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress [Yahoo! Finance]

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF AI-Immunology™ powered vaccines, will present preclinical Proof-of-Concept for its precision cancer vaccine concept, targeting non-conventional ERV (endogenous retroviru [Read more]